We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Hologic Displays Automated Solutions And Expansive Diagnostic Menu to Help Labs Grow at AACC 2021

By LabMedica International staff writers
Posted on 29 Sep 2021

Image: ThinPrep Genesis Processor (Photo courtesy of Hologic, Inc.)

Image: ThinPrep Genesis Processor (Photo courtesy of Hologic, Inc.)

Hologic, Inc. (Marlborough, MA, USA) displayed its automated solutions and expansive diagnostic menu that are designed to help labs grow at the 2021 AACC Annual Scientific Meeting & Clinical Lab Expo.

The annual event held in Atlanta on September 26-30 by the American Association for Clinical Chemistry (AACC) showcased the cutting edge science and technology shaping the future of laboratory medicine. Hologic demonstrated its range of Panther instrumentation and Aptima and Panther Fusion assays alongside its new ThinPrep Genesis Processor at the event.

Hologic demonstrated its Panther Scalable Solutions that allow labs to expand their testing menu while adding on flexibility, capacity and walkaway time. The Panther system serves as the foundation of Hologic’s automation with the option to add on the Panther Fusion module, Panther Plus, Panther Link and Panther Trax. Panther Scalable Solutions provide an economical and scalable path to lab’s growth today and into the future. Also on display at AACC 2021 was Hologic’s broad menu of Aptima and Panther Fusion assays to run on scalable automation that can help guide patient care and enable early detection.

In addition, Hologic highlighted its new ThinPrep Genesis Processor which offers automated chain of custody, streamlined cytology processing, and hands-free sample aliquoting in a single instrument to promote confidence in results while optimizing lab performance. The ThinPrep Genesis Processor is an intuitive, versatile, and scalable solution for laboratories of all volumes. The best-in-class system helps cytology labs automate their processes – decreasing the need for hands-on labor and increasing laboratory efficiencies.

Related Links:
Hologic, Inc.

Visit expo >

Gold Member

Fibrinolysis Assay

HemosIL Fibrinolysis Assay Panel

POC Helicobacter Pylori Test Kit
Hepy Urease Test

HBV DNA Test

GENERIC HBV VIRAL LOAD VER 2.0

Gold Member

Hematology Analyzer

Medonic M32B

ADLM

Latest AACC 2021 News

Channels

Clinical Chemistry

view channel

POC Breath Diagnostic System to Detect Pneumonia-Causing Pathogens

Pseudomonas aeruginosa is a major cause of hospital-acquired and ventilator-associated pneumonia, particularly in lung transplant recipients and patients with structural lung disease. Its ability to form... Read more

Online Tool Detects Drug Exposure Directly from Patient Samples

Doctors often rely on patient interviews and medical records to determine what medications a person has taken, but this information is frequently incomplete. People may forget drugs they used, take over-the-counter... Read more

Image: The ARi-FL fluorescent probe offers a clearer view of tumor behavior and treatment resistance (J. Med. Chem. 2025, 68, 15, 15812-15827)

Chemical Imaging Probe Could Track and Treat Prostate Cancer

Prostate cancer remains a leading cause of illness and death among men, with many patients eventually developing resistance to standard hormone-blocking therapies. These drugs often lose effectiveness... Read more

Mismatch Between Two Common Kidney Function Tests Indicates Serious Health Problems

Creatinine has long been the standard for measuring kidney filtration, while cystatin C — a protein produced by all human cells — has been recommended as a complementary marker because it is influenced... Read more

Molecular Diagnostics

view channel

$Image: Scout\'s patented molecular technology delivers results matching high-complexity PCR 99% of the time (Photo courtesy of Scout Health)$

STI Molecular Test Delivers Rapid POC Results for Treatment Guidance

An affordable, rapid molecular diagnostic for sexually transmitted infections (STIs) has the potential to be globally relevant, particularly in resource-limited settings where rapid, point-of-care results... Read more

Blood Biomarker Improves Early Brain Injury Prognosis After Cardiac Arrest

After a cardiac arrest, many patients remain unconscious for days, leaving doctors and families facing uncertainty about whether meaningful recovery is possible. Current tools to assess brain damage, including... Read more

Biomarkers Could Identify Patients at High Risk of Severe AKI After Major Surgery

Acute kidney injury is one of the most common and dangerous complications after major surgery, particularly among patients in intensive care. Even mild impairment of kidney function can lead to long-term... Read more

CLIA Test Identifies Head and Neck Cancer Recurrence from Post-Surgical Lymphatic Fluid

While the lymphatic system’s critical role in metastasis has long been recognized, routine access to patient lymph has been elusive. Now, a non-invasive process can access lymph through the collection... Read more

Hematology

view channel

MRD Tests Could Predict Survival in Leukemia Patients

Acute myeloid leukemia is an aggressive blood cancer that disrupts normal blood cell production and often relapses even after intensive treatment. Clinicians currently lack early, reliable markers to predict... Read more

Platelet Activity Blood Test in Middle Age Could Identify Early Alzheimer’s Risk

Early detection of Alzheimer’s disease remains one of the biggest unmet needs in neurology, particularly because the biological changes underlying the disorder begin decades before memory symptoms appear.... Read more

Image: Sickle cell disease patients with higher levels of RMVs, AMVs, and EMVs were found to have more severe disease (Photo courtesy of Adobe Stock)

Microvesicles Measurement Could Detect Vascular Injury in Sickle Cell Disease Patients

Assessing disease severity in sickle cell disease (SCD) remains challenging, especially when trying to predict hemolysis, vascular injury, and risk of complications such as vaso-occlusive crises.... Read more

ADLM’s New Coagulation Testing Guidance to Improve Care for Patients on Blood Thinners

Direct oral anticoagulants (DOACs) are one of the most common types of blood thinners. Patients take them to prevent a host of complications that could arise from blood clotting, including stroke, deep... Read more

Immunology

view channel

Blood Test Could Identify Colon Cancer Patients to Benefit from NSAIDs

Colon cancer remains a major cause of cancer-related illness, with many patients facing relapse even after surgery and chemotherapy. Up to 40% of people with stage III disease experience recurrence, highlighting... Read more

Blood Test Could Detect Adverse Immunotherapy Effects

Immune checkpoint inhibitors have transformed cancer treatment, but they can also trigger serious immune-related adverse events that damage healthy organs and may become life-threatening if not detected early.... Read more

Routine Blood Test Can Predict Who Benefits Most from CAR T-Cell Therapy

CAR T-cell therapy has transformed treatment for patients with relapsed or treatment-resistant non-Hodgkin lymphoma, but many patients eventually relapse despite an initial response. Clinicians currently... Read more

New Test Distinguishes Vaccine-Induced False Positives from Active HIV Infection

Since HIV was identified in 1983, more than 91 million people have contracted the virus, and over 44 million have died from related causes. Today, nearly 40 million individuals worldwide live with HIV-1,... Read more

Microbiology

view channel

Image: A digital tree built from DNA-like connections represents how scientists trace the ancestry of microbes

Breakthroughs in Microbial Analysis to Enhance Disease Prediction

Microorganisms shape human health, ecosystems, and the planet’s climate, yet identifying them and understanding how they are related remains a major scientific challenge. Even with modern DNA sequencing,... Read more

Blood-Based Diagnostic Method Could Identify Pediatric LRTIs

Lower-respiratory tract infections (LRTIs) are a leading cause of illness and death worldwide, and pneumonia is the leading infectious cause of death in children under five, claiming the lives of over... Read more

Rapid Diagnostic Test Matches Gold Standard for Sepsis Detection

Sepsis kills 11 million people worldwide every year and generates massive healthcare costs. In the USA and Europe alone, sepsis accounts for USD 100 billion in annual hospitalization expenses.... Read more

Rapid POC Tuberculosis Test Provides Results Within 15 Minutes

Tuberculosis remains one of the world’s deadliest infectious diseases, and reducing new cases depends on identifying individuals with latent infection before it progresses. Current diagnostic tools often... Read more

Pathology

view channel

Rapid Low-Cost Tests Can Prevent Child Deaths from Contaminated Medicinal Syrups

Medicinal syrups contaminated with toxic chemicals have caused the deaths of hundreds of children worldwide, exposing a critical gap in how these products are tested before reaching patients.... Read more

Image: Flowchart representing sample collections and small EV isolations from tissue, saliva, and plasma of HNC patients (A Jangholi et al., VIEW (2025). DOI: https://doi.org/10.1002/VIW.20250081)

Tumor Signals in Saliva and Blood Enable Non-Invasive Monitoring of Head and Neck Cancer

Head and neck cancers are among the most aggressive malignancies worldwide, with nearly 900,000 new cases diagnosed each year. Monitoring these cancers for recurrence or relapse typically relies on tissue... Read more

Image: Everyday health conditions can shape Alzheimer’s blood test results (Photo courtesy of Shutterstock)

Common Health Issues Can Influence New Blood Tests for Alzheimer’s Disease

Blood-based tests for Alzheimer’s disease are transforming diagnosis by offering a simpler alternative to spinal taps and brain imaging. However, many people evaluated at memory clinics also live with... Read more

Blood Test Formula Identifies Chronic Liver Disease Patients with Higher Cancer Risk

Chronic liver disease affects millions worldwide and can progress silently to hepatocellular carcinoma (HCC), one of the deadliest cancers globally. While surveillance guidelines exist for patients with... Read more

Technology

view channel

Machine Learning Models Diagnose ALS Earlier Through Blood Biomarkers

Amyotrophic lateral sclerosis (ALS) is a rapidly progressive neurodegenerative disease that is notoriously difficult to diagnose in its early stages. Early symptoms often overlap with other neurological... Read more

Artificial Intelligence Model Could Accelerate Rare Disease Diagnosis

Identifying which genetic variants actually cause disease remains one of the biggest challenges in genomic medicine. Each person carries tens of thousands of DNA changes, yet only a few meaningfully alter... Read more

Image: The technology can diagnose head and neck cancer early with a drop of saliva (Photo courtesy of Adobe Stock)

AI Saliva Sensor Enables Early Detection of Head and Neck Cancer

Early detection of head and neck cancer remains difficult because the disease produces few or no symptoms in its earliest stages, and lesions often lie deep within the head or neck, where biopsy or endoscopy... Read more

Image: The screen-printed electrochemical sensor (Photo courtesy of UT Dallas)

AI-Powered Biosensor Technology to Enable Breath Test for Lung Cancer Detection

Detecting lung cancer early remains one of the biggest challenges in oncology, largely because current tools are invasive, expensive, or unable to identify the disease in its earliest phases.... Read more

Industry

view channel

BD and Penn Institute Collaborate to Advance Immunotherapy through Flow Cytometry

BD (Becton, Dickinson and Company, Franklin Lakes, NJ, USA) has entered into a strategic collaboration with the Institute for Immunology and Immune Health (I3H, Philadelphia, PA, USA) at the University... Read more

Abbott Acquires Cancer-Screening Company Exact Sciences

Abbott (Abbott Park, IL, USA) has entered into a definitive agreement to acquire Exact Sciences (Madison, WI, USA), enabling it to enter and lead in fast-growing cancer diagnostics segments.... Read more

$Image: Freenome will evaluate Roche\'s forthcoming SBX technology for future development applications (Photo courtesy of Roche)$

Roche and Freenome Collaborate to Develop Cancer Screening Tests

Roche (Basel, Switzerland) and Freenome (Brisbane, CA, USA have entered into a strategic collaboration to commercialize Freenome's cancer screening technology in international markets.... Read more

Co-Diagnostics Forms New Business Unit to Develop AI-Powered Diagnostics

Co-Diagnostics, Inc. (Salt Lake City, UT, USA) has formed a new artificial intelligence (AI) business unit to integrate the company's existing and planned AI applications into its Co-Dx Primer Ai platform.... Read more